Annual Report

Overview

The report describes Almirall's 2013 expansion through over 30 product launches and the acquisition of Aqua Pharmaceuticals, strengthening its dermatology presence in the United States. It also highlights continued investment in R&D, with 18 % of sales invested in research and development. On sustainability, the company reports renewed ISO 14001, ISO 50001 and OHSAS 18001 certifications, alongside 5,129 tonnes of waste managed at its worksites.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2013
Period: 1 January 2013 – 31 December 2013
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services